These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29739090)

  • 1. Expression Analysis of MicroRNA-222 in Breast Cancer.
    Amini S; Abak A; Estiar MA; Montazeri V; Abhari A; Sakhinia E
    Clin Lab; 2018 Apr; 64(4):491-496. PubMed ID: 29739090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study).
    Abak A; Amini S; Estiar MA; Montazeri V; Sakhinia E; Abhari A
    Clin Lab; 2018 Jan; 64(1):169-175. PubMed ID: 29479893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A; Babashah S; Garshasbi M
    J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
    Fan X; Huang X; Li Z; Ma X
    J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
    Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
    Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
    Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer.
    Erturk E; Ari F; Onur OE; Mustafa Gokgoz S; Tolunay S
    Mol Biol Rep; 2024 Oct; 51(1):1030. PubMed ID: 39352561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
    Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
    Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival.
    Li Y; Hong F; Yu Z
    J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.